USA Continuous Glucose Monitoring (CGM) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A continuous glucose monitor is a device used for monitoring blood glucose on a continual basis by people with type I diabetes.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Continuous Glucose Monitoring (CGM) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Continuous Glucose Monitoring (CGM) market. Detailed analysis of key players, along with key growth strategies adopted by Continuous Glucose Monitoring (CGM) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Medtronic

    • Pfizer

    • Novo Nordisk

    • Ypsomed

    • GlySens

    • Baxter

    • Animas

    • Abbott Laboratories

    By Type:

    • Transmitters

    • Sensors

    • Insulin Pumps

    By End-User:

    • Hospitals

    • Homecare Settings

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Continuous Glucose Monitoring (CGM) Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Transmitters from 2016 to 2027

      • 1.3.2 USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Sensors from 2016 to 2027

      • 1.3.3 USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Insulin Pumps from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Hospitals from 2016 to 2027

      • 1.4.2 USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Homecare Settings from 2016 to 2027

      • 1.4.3 USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Continuous Glucose Monitoring (CGM) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Continuous Glucose Monitoring (CGM) by Major Types

      • 3.4.1 Market Size and Growth Rate of Transmitters

      • 3.4.2 Market Size and Growth Rate of Sensors

      • 3.4.3 Market Size and Growth Rate of Insulin Pumps

    4 Segmentation of Continuous Glucose Monitoring (CGM) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Continuous Glucose Monitoring (CGM) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Continuous Glucose Monitoring (CGM) in Hospitals

      • 4.4.2 Market Size and Growth Rate of Continuous Glucose Monitoring (CGM) in Homecare Settings

      • 4.4.3 Market Size and Growth Rate of Continuous Glucose Monitoring (CGM) in Others

    5 Market Analysis by Regions

    • 5.1 USA Continuous Glucose Monitoring (CGM) Production Analysis by Regions

    • 5.2 USA Continuous Glucose Monitoring (CGM) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Continuous Glucose Monitoring (CGM) Landscape Analysis

    • 6.1 West USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major Types

    • 6.2 West USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major End-Users

    7 South USA Continuous Glucose Monitoring (CGM) Landscape Analysis

    • 7.1 South USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major Types

    • 7.2 South USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major End-Users

    8 Middle West USA Continuous Glucose Monitoring (CGM) Landscape Analysis

    • 8.1 Middle West USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major Types

    • 8.2 Middle West USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major End-Users

    9 Northeast USA Continuous Glucose Monitoring (CGM) Landscape Analysis

    • 9.1 Northeast USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major Types

    • 9.2 Northeast USA Continuous Glucose Monitoring (CGM) Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Medtronic

        • 10.1.1 Medtronic Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Pfizer

        • 10.2.1 Pfizer Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Novo Nordisk

        • 10.3.1 Novo Nordisk Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Ypsomed

        • 10.4.1 Ypsomed Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 GlySens

        • 10.5.1 GlySens Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Baxter

        • 10.6.1 Baxter Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Animas

        • 10.7.1 Animas Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Abbott Laboratories

        • 10.8.1 Abbott Laboratories Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Transmitters from 2016 to 2027

    • Figure USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Sensors from 2016 to 2027

    • Figure USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Insulin Pumps from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Homecare Settings from 2016 to 2027

    • Figure USA Continuous Glucose Monitoring (CGM) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Continuous Glucose Monitoring (CGM) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Continuous Glucose Monitoring (CGM)

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Continuous Glucose Monitoring (CGM) by Different Types from 2016 to 2027

    • Table Consumption Share of Continuous Glucose Monitoring (CGM) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Transmitters

    • Figure Market Size and Growth Rate of Sensors

    • Figure Market Size and Growth Rate of Insulin Pumps

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Continuous Glucose Monitoring (CGM) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Continuous Glucose Monitoring (CGM) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Homecare Settings

    • Figure Market Size and Growth Rate of Others

    • Table USA Continuous Glucose Monitoring (CGM) Production by Regions

    • Table USA Continuous Glucose Monitoring (CGM) Production Share by Regions

    • Figure USA Continuous Glucose Monitoring (CGM) Production Share by Regions in 2016

    • Figure USA Continuous Glucose Monitoring (CGM) Production Share by Regions in 2021

    • Figure USA Continuous Glucose Monitoring (CGM) Production Share by Regions in 2027

    • Table USA Continuous Glucose Monitoring (CGM) Consumption by Regions

    • Table USA Continuous Glucose Monitoring (CGM) Consumption Share by Regions

    • Figure USA Continuous Glucose Monitoring (CGM) Consumption Share by Regions in 2016

    • Figure USA Continuous Glucose Monitoring (CGM) Consumption Share by Regions in 2021

    • Figure USA Continuous Glucose Monitoring (CGM) Consumption Share by Regions in 2027

    • Table West USA Continuous Glucose Monitoring (CGM) Consumption by Types from 2016 to 2027

    • Table West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types from 2016 to 2027

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2016

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2021

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2027

    • Table West USA Continuous Glucose Monitoring (CGM) Consumption by End-Users from 2016 to 2027

    • Table West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2016

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2021

    • Figure West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2027

    • Table South USA Continuous Glucose Monitoring (CGM) Consumption by Types from 2016 to 2027

    • Table South USA Continuous Glucose Monitoring (CGM) Consumption Share by Types from 2016 to 2027

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2016

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2021

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2027

    • Table South USA Continuous Glucose Monitoring (CGM) Consumption by End-Users from 2016 to 2027

    • Table South USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2016

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2021

    • Figure South USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2027

    • Table Middle West USA Continuous Glucose Monitoring (CGM) Consumption by Types from 2016 to 2027

    • Table Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2016

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2021

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2027

    • Table Middle West USA Continuous Glucose Monitoring (CGM) Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2016

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2021

    • Figure Middle West USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2027

    • Table Northeast USA Continuous Glucose Monitoring (CGM) Consumption by Types from 2016 to 2027

    • Table Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2016

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2021

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by Types in 2027

    • Table Northeast USA Continuous Glucose Monitoring (CGM) Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2016

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2021

    • Figure Northeast USA Continuous Glucose Monitoring (CGM) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Medtronic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medtronic

    • Figure Sales and Growth Rate Analysis of Medtronic

    • Figure Revenue and Market Share Analysis of Medtronic

    • Table Product and Service Introduction of Medtronic

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Ypsomed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ypsomed

    • Figure Sales and Growth Rate Analysis of Ypsomed

    • Figure Revenue and Market Share Analysis of Ypsomed

    • Table Product and Service Introduction of Ypsomed

    • Table Company Profile and Development Status of GlySens

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlySens

    • Figure Sales and Growth Rate Analysis of GlySens

    • Figure Revenue and Market Share Analysis of GlySens

    • Table Product and Service Introduction of GlySens

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of Animas

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Animas

    • Figure Sales and Growth Rate Analysis of Animas

    • Figure Revenue and Market Share Analysis of Animas

    • Table Product and Service Introduction of Animas

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.